Home › NDC Lookup › RxCUI directory › RxCUI 2694320

1 ML testosterone cypionate 200 MG/ML Injection [Azmiro] — RxCUI 2694320

RxNorm drug concept · Semantic branded drug
RxCUI 2694320 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2694320
Official name1 ML testosterone cypionate 200 MG/ML Injection [Azmiro]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAzmiro 200 MG per 1 ML Injection; AZMIRO 200 MG in 1 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Testosterone Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Testosterone gel is a hormone replacement therapy for adult men whose bodies don't produce enough testosterone on their own — a condition called hypogonadism. This can happen becau...
  • What exactly is testosterone gel used for?
  • Yes, location really matters. Testosterone gel 1.62% goes on the shoulders and upper arms only — not the abdomen, chest, genitals, armpits, or knees. Apply it to clean, dry, unbrok...
  • How do I apply it correctly, and does it matter where I put it?
📖 Read our full Testosterone Transdermal Patch guide →

🕸️ Concept Web — How 1 ML testosterone cypionate 200 MG/ML Injection... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML testosterone cypionate 200 MG/ML Injection [Azmiro] RxCUI 2694320

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Testosterone 10379
    • Testosterone cypionate 835827
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Azmiro 2694311
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Testosterone Injection 1738784
    • Testosterone cypionate Injection 2648392
    • Testosterone Injectable Product 1164841
    • Testosterone cypionate Injectable Product 2663142
    • Testosterone Injection [Azmiro] 2694318
    • Testosterone cypionate Injection [Azmiro] 2694319
    • Azmiro Injectable Product 2694313
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML testosterone cypionate 200 MG/ML Injection SCD · 2047882
  • Testosterone cypionate 200 MG/ML SCDC · 835839
  • Testosterone Injection SCDF · 1738784
  • Testosterone cypionate Injection SCDFP · 2648392
  • Testosterone Injectable Product SCDG · 1164841
  • Testosterone cypionate Injectable Product SCDGP · 2663142

Brand-Name Concepts

  • Testosterone cypionate 200 MG/ML [Azmiro] SBDC · 2694312
  • Testosterone Injection [Azmiro] SBDF · 2694318
  • Testosterone cypionate Injection [Azmiro] SBDFP · 2694319
  • Azmiro Injectable Product SBDG · 2694313
  • Azmiro BN · 2694311

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2694320 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24338-0055-01 1 SYRINGE, GLASS in 1 CARTON (24338-055-01) / 1 mL in 1 SYR... AZMIRO Azurity Pharmaceuticals, Inc. 2024-10-04
24338-0056-01 1 VIAL in 1 CARTON (24338-056-01) / 1 mL in 1 VIAL AZMIRO Azurity Pharmaceuticals, Inc. 2024-10-04
Observed labelers: Azurity Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1072 Inj, testosterone, azmiro 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.